This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Navigant Acquires Cymetrix, A Leading Healthcare Revenue Cycle Management Firm

Stocks in this article: NCI

Navigant (NYSE: NCI) announced today that it has acquired Cymetrix Corporation, a privately held revenue cycle management firm that specializes in providing outsourcing services to hospital and healthcare networks. The addition of Cymetrix’s approximately 600 business process outsourcing employees significantly enhances Navigant Healthcare’s existing physician revenue cycle outsourcing capabilities, which are offered through Navigant’s Alleviant subsidiary, and establishes Navigant Healthcare as a leading provider of end-to-end revenue cycle management services. The newly acquired company will operate as Navigant Healthcare Cymetrix.

Under the terms of the acquisition agreement, Navigant paid approximately $75 million in cash at closing to acquire 100% of the stock of Cymetrix and may pay up to an additional $25 million to the selling stockholders based on the acquired company’s achievement of certain post-closing performance targets.

“The acquisition of Cymetrix aligns with our strategic growth plans and is transformative for Navigant – creating new opportunities for us to evolve and expand our business platform beyond consulting services to incorporate more data analytics products, technology-enabled solutions, and operations outsourcing,” stated Julie Howard, Navigant Chairman and Chief Executive Officer. “These complementary and adjacent solutions extend the value we can bring to our clients from strategy and advisory services all the way through to execution. Moreover, the acquisition adds new recurring revenue streams with higher predictability and offers us a catalyst for accelerated revenue growth.”

Founded in 2001, Cymetrix is a national leader in providing healthcare organizations and hospital-affiliated physician practices with end-to-end revenue cycle outsourcing solutions. Cymetrix creates custom solutions that are designed to deliver sustained improvement in performance and profitability while ensuring the patient experience and hospital mission are served. Cymetrix Chief Executive Officer, Michael Halberda, will continue to lead the company’s day-to-day operations as part of Navigant Healthcare.

“Cymetrix’s client base spans more than 200 hospitals and health networks nationwide, and it is a leader in helping clients improve their operating margins while focusing on clinical care,” said David Zito, Managing Director and Navigant Healthcare segment leader. “Market forces like ICD-10 and the move toward a pay-for-performance system are placing new demands and extreme cost pressures on hospitals. The increasing complexity in the revenue cycle process will encourage healthcare providers to consider outsourcing to alleviate that aspect of administration. With the Cymetrix team, we are now able to offer our clients a premier option for devising the best strategy as well as implementation services.”

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs